Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Italy,Turkey,Bulgaria,United Kingdom,United States,Canada,Czech Republic,Germany,Spain,Ukraine - Phase: complete
nct
Update Il y a 5 ans
Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
The purpose of this study is to compare progression free survival for SU011248 [sutent (sunitinib malate)] versus standard of care therapy in patients with previously treated, advanced, triple receptor negative (ER, PR, HER2) locally recurrent or metastatic breast cancer.
Country
Bulgaria
,
Canada
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Spain
,
Turkey
,
Ukraine
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1